USD
EUR
GBP
CAD
AUD
CHF
HKD
JPY
RUB
BRL
CLP
NOK
DKK
SEK
KRW
ILS
MXN
CNY
SAR
SGD
NZD
ARS
INR
COP
AED
Home
Products
Peptides
Nootropics
Steriods
Sarms
Custom synthesis
Others
About Us
About Us
Sitemap
FAQ
Blog
News
Download
Contact Us
0
Home
Products
Peptides
Nootropics
Steriods
Sarms
Custom synthesis
Others
About Us
About Us
Sitemap
FAQ
Blog
News
Download
Contact Us
Home
>
News
News
Voxelotor, a drug for sickle cell disease
May 10, 2023
05-10
2023
Voxelotor, a drug for sickle cell disease
Name: Voxelotor
CAS: 1446321-46-5
Originating company: Global Blood Therapeutics
Indication: Sickle cell disease
NASH Research Update│Resmetirom Receives Breakthrough Therapy Designation from FDA
May 10, 2023
05-10
2023
NASH Research Update│Resmetirom Receives Breakthrough Therapy Designation from FDA
NASH treatment drug hits high note: Resmetirom Phase III progress excellent
May 09, 2023
05-09
2023
NASH treatment drug hits high note: Resmetirom Phase III progress excellent
AstraZeneca's 'semitinib' approved in China
May 09, 2023
05-09
2023
AstraZeneca's 'semitinib' approved in China,Company News
semitinib (AstraZeneca/Mercedon), binitinib (Pfizer/Pierre Fabre/Ono Pharmaceutical), cobimetinib (Roche/Exelixis), and trametinib (Japan Tobacco/Novartis)
Bayer's investigational small molecule 2023
May 08, 2023
05-08
2023
Bayer's investigational small molecule 2023
Runcaciguat (BAY 1101042) CAS: 1402936-61-1
Zabedosertib (BAY 1834845） CAS:1931994-81-8
Elinzanetant CAS: 929046-33-3
sarms4muscle-oxiracetam,piracetampowder products video
May 06, 2023
05-06
2023
sarms4muscle- oxiracetam ,piracetampowder products video
May 05, 2023
05-05
2023
New Small Molecule Drugs Approved by FDA in 2023Q1 and Drug Design Ideas
May 05, 2023
05-05
2023
New Small Molecule Drugs Approved by FDA in 2023Q1 and Drug Design Ideas
Brenzavvy (bexagliflozin)
Jayprica (Pirtobrutinib)
Orserdu (elacestrant)
Jesduvroq (daprodustat)
Filspari (sparsentan)
Skyclarys (omaveloxolone)
Zavzpret (zavegepant)
Daybue (trofinetide)
Rezzayo (rezafungin)
Joenja (leniolisib)
The Science Behind Aniracetam Capsules and Their Effects on the Brain
Apr 27, 2023
04-27
2023
JAK/HDAC bispecific inhibitor developed to be efficient against solid tumors and malignant leukemia
Apr 26, 2023
04-26
2023
JAK/HDAC bispecific inhibitor developed to be efficient against solid tumors and malignant leukemia
1
...
5
6
7
8
9
10
11
page:
Go
